US Domestic Nitrile Glove Output Hits 1.2 Billion Units After $950M Outlay

The Bloomberg investigation documents repeated plant delays at three subsidized facilities in Texas, Ohio, and South Carolina. Raw material feedstock, specialized dipping lines, and skilled operators remain unavailable at scale inside the United States. Import data from the Census Bureau show Malaysia supplied 82 percent of US nitrile glove volume in the first half of 2026.

Energy and labor cost differentials explain most of the shortfall. Malaysian plants operate at $0.08 per glove; equivalent US sites require $0.19 even after subsidies. Prior COVID-era Defense Production Act awards produced the same pattern: initial capacity announcements followed by multi-year shortfalls and quiet contract modifications.

GAO-24-1072 and Commerce Department Section 232 filings record identical constraints across masks, gowns, and syringes. Reshoring metrics therefore track capital deployed rather than sustained output. No domestic project has yet cleared the 5 percent domestic share threshold without ongoing federal offtake guarantees.

Tariff increases scheduled for 2027 will test whether cost gaps can be closed without permanent price supports. Current contract structures lock buyers to foreign suppliers through 2028.